Allara

Allara Health is a US-based telehealth company focused on women's health, offering personalized treatment for complex hormonal, metabolic, and gynecological conditions through a holistic approach and dedicated care teams. Founded in 2020 in New York, US, Allara Health specializes in telehealth services for women's health. The company has raised USD 26. 00 mn in its latest funding round, Series B, led by Index Ventures, which aims to enhance access to specialized hormonal health care.

Rachel Blank serves as the CEO and founder, bringing expertise from her previous ventures. Allara has completed four deals to date, with the most recent deal dated January 24, 2025. Allara Health specializes in telehealth services focused on women's health, addressing complex hormonal, metabolic, and gynecological conditions. The core offerings include personalized treatment plans developed by dedicated care teams that consist of board-certified medical providers and registered dietitians.

These plans encompass comprehensive lab work, advanced testing for hormonal and metabolic health, and ongoing support through virtual appointments. Allara's services cater to women diagnosed with conditions such as PCOS, insulin resistance, endometriosis, and various reproductive health issues, ensuring a holistic approach to patient care. The company primarily operates in the United States, providing its specialized health services to patients across numerous states, including California, Texas, New York, and Florida. Allara Health generates revenue through a subscription-based model, allowing patients to access a combination of medical and nutrition services tailored to their unique health needs.

Patients engage in regular virtual visits with their dedicated care teams, which include one medical provider and one registered dietitian, creating a personalized healthcare experience. The company accepts various insurance plans and offers self-pay options for those without coverage, facilitating a diverse client base. Revenue is driven by monthly subscription fees that encompass comprehensive care, including ongoing lab work, treatment adjustments, and access to the Patient Success team. These structured transactions ensure that patients receive continuous support and monitoring, enhancing their overall health outcomes.

With the recent Series B funding of USD 26. 00 mn, Allara Health aims to expand its telemedicine services significantly. The investment will focus on increasing access to specialized care for women's hormonal health. Although specific new products have not been disclosed, the company is expected to enhance its service offerings and reach new geographic markets in the coming year.